Piramal Pharma Limited CC-Jan26.pdf · 2026-01-29
This increased demand conditions you have observed in December quarter versus prior periods, is this in the research and development area of CDMO or even in the manufacturing area as well?
I just have one question regarding this large product for which we are seeing the inventory destocking. I just wanted to know whether the specs are fungible within markets as in across markets, which means basically what I am trying to understand is that is the same product, if it can be sold in the U.S., can it be sold in China also? And if you see, let's say, lesser of a demand in China, can that product be then sold to in the U.S.? Is that a possibility or the specs are different for different markets?